Charles Swingland
Direttore/Membro del Consiglio presso Sensyne Health Holdings Ltd.
Profilo
Charles Stuart Webb Swingland founded Niox Group Plc in 2006, where he worked as Non-Executive Director from 2006 to 2017.
Mr. Swingland also currently works at Sensyne Health Holdings Ltd., as Deputy Chairman from 2014 and Adiga Life Sciences, Inc., as Director.
Mr. Swingland also formerly worked at Sensyne Health Ltd., as Non-Executive Chairman in 2019, Powderject Pharmaceuticals Plc, as Secretary, Executive Director & General Counsel in 2003, Glide Pharmaceutical Technologies Ltd., as Non-Executive Director, Akamis Bio Ltd., as Non-Executive Director, Cephalon, Inc., as Principal, Zeneus Pharma Ltd., as General Counsel from 2004 to 2012, and Circassia Ltd., as General Counsel from 1998 to 2003.
Posizioni attive di Charles Swingland
Società | Posizione | Inizio |
---|---|---|
Sensyne Health Holdings Ltd.
Sensyne Health Holdings Ltd. Electronic Production EquipmentElectronic Technology Sensyne Health Holdings Ltd. provides wireless charging technology. It focuses on developing wireless energy devices and wireless sensor networks. The company was founded by Elspeth Drayson, Paul R. Drayson and Manuel Pinuela in April 2014 and is headquartered in London, the United Kingodm. | Direttore/Membro del Consiglio | 01/01/2014 |
Adiga Life Sciences, Inc.
Adiga Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Adiga Life Sciences, Inc. operates as a healthcare company that conducts medical researches. It develops technologies to control immune function in allergic and auto immune diseases. The company was founded on November 25, 2008 and is headquartered in Hamilton, Canada. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Charles Swingland
Società | Posizione | Fine |
---|---|---|
SENSYNE HEALTH PLC | Presidente | 04/10/2019 |
NIOX GROUP PLC | Fondatore | 26/05/2017 |
Circassia Ltd.
Circassia Ltd. Pharmaceuticals: OtherHealth Technology Circassia Ltd. develops medicines for allergic and auto-immune diseases. The company was founded by Anthony Barrington Kay and Mark Larché on December 29, 1998 and is headquartered in Oxford, the United Kingdom. | Direttore/Membro del Consiglio | 08/07/2003 |
Powderject Pharmaceuticals Plc
Powderject Pharmaceuticals Plc Medical SpecialtiesHealth Technology Powderject Pharmaceuticals Plc develops pharmaceutical products. It offers researching, developing, manufacturing and marketing for existing and next generation vaccines. The company was founded in 1993 and is located in Oxford, UK | Direttore/Membro del Consiglio | 01/01/2003 |
Cephalon, Inc.
Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Corporate Officer/Principal | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
NIOX GROUP PLC | Health Services |
SENSYNE HEALTH PLC | Commercial Services |
Aziende private | 8 |
---|---|
Glide Pharmaceutical Technologies Ltd.
Glide Pharmaceutical Technologies Ltd. Pharmaceuticals: MajorHealth Technology Glide Pharmaceutical Technologies Ltd. developed and manufactured pharmaceutical products. The firm developed SDI, a solid dose injector system to improve compliance in patients self-administering long term therapy. Its pipeline of solid dose formulations includes octreotide, teriparatide, and anthrax and influenza vaccines. It also engaged in developing a non-invasive diagnostic technology that primarily focuses on prostate cancer, which aims to identify clinically significant disease based on a biochemical marker. The company was founded by Charles David Ogilvy Potter on 6th March, 2001 and was headquartered in Abingdon, the United Kingdom. | Health Technology |
Circassia Ltd.
Circassia Ltd. Pharmaceuticals: OtherHealth Technology Circassia Ltd. develops medicines for allergic and auto-immune diseases. The company was founded by Anthony Barrington Kay and Mark Larché on December 29, 1998 and is headquartered in Oxford, the United Kingdom. | Health Technology |
Zeneus Pharma Ltd.
Zeneus Pharma Ltd. Medical DistributorsDistribution Services Zeneus Pharma Ltd. provides pharmaceutical products. It offers license to late-stage development, pre and post-approval, and marketing services across Europe for specialty hospital medicines. The company was founded in 2004 by Bryan Morton and is headquartered in Oxford, UK. | Distribution Services |
Akamis Bio Ltd.
Akamis Bio Ltd. BiotechnologyHealth Technology Akamis Bio Ltd. operates as a biotechnology company which develops novel therapeutics that addresses cancer and other clinically unmet diseases. Its products include Enadenotucirev, Espindolol and AbEnAd. The firm also develops treatments based upon the research phase vaccine platform PolySTAR, which combines recombinant viral vectors with polymers to shield them from the immune system, and the research phase adjuvant and immunotherapeutic platform PolyMAP, which combines polymers with synthetic adjuvants to significantly enhance the effectiveness of vaccines. The company was founded by Andrew Justin Stewart Coats and Stefan D. Anker on November 17, 2006 and is headquartered in Abingdon, the United Kingdom. | Health Technology |
Cephalon, Inc.
Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Health Technology |
Powderject Pharmaceuticals Plc
Powderject Pharmaceuticals Plc Medical SpecialtiesHealth Technology Powderject Pharmaceuticals Plc develops pharmaceutical products. It offers researching, developing, manufacturing and marketing for existing and next generation vaccines. The company was founded in 1993 and is located in Oxford, UK | Health Technology |
Sensyne Health Holdings Ltd.
Sensyne Health Holdings Ltd. Electronic Production EquipmentElectronic Technology Sensyne Health Holdings Ltd. provides wireless charging technology. It focuses on developing wireless energy devices and wireless sensor networks. The company was founded by Elspeth Drayson, Paul R. Drayson and Manuel Pinuela in April 2014 and is headquartered in London, the United Kingodm. | Electronic Technology |
Adiga Life Sciences, Inc.
Adiga Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Adiga Life Sciences, Inc. operates as a healthcare company that conducts medical researches. It develops technologies to control immune function in allergic and auto immune diseases. The company was founded on November 25, 2008 and is headquartered in Hamilton, Canada. | Health Technology |
- Borsa valori
- Insiders
- Charles Swingland